Temple syndrome due to paternal 14q32.2 hypomethylation is a rare genetic condition that affects growth, development, and puberty. Early signs of Temple syndrome due to paternal 14q32.2 hypomethylation often appear in infancy or childhood and can include low muscle tone, feeding difficulties, short stature, and small hands and feet. Not everyone will have the same experience, and many living with Temple syndrome due to paternal 14q32.2 hypomethylation also have a tendency to gain weight easily and may start puberty earlier than expected. It is usually a lifelong condition caused by altered gene control in a region of chromosome 14, but life expectancy is often near typical when complications are recognized and managed. Treatment for Temple syndrome due to paternal 14q32.2 hypomethylation focuses on supportive care, such as nutrition support, developmental therapies, monitoring growth and puberty, and treatment for hormone or weight-related concerns.
How many people live with Temple syndrome due to paternal 14q32.2 hypomethylation?
Temple syndrome caused by paternal 14q32.2 hypomethylation is so rare that no reliable estimate is available for how many people are living with it worldwide, and no separate U.S. estimate is consistently reported either (Orphanet, 2024; Genetic and Rare Diseases Information Center, 2024). Only small numbers of diagnosed cases have been published, so the true worldwide and U.S. numbers are unknown.
Overview
Temple syndrome due to paternal 14q32.2 hypomethylationSymptoms
Temple syndrome often involves low muscle tone, feeding trouble, and slow growth in infancy. Later, many living with Temple syndrome develop early puberty, short height, and a tendency to gain extra weight.
Outlook and prognosis
Temple syndrome due to paternal 14q32.2 hypomethylation is usually compatible with a normal lifespan. Many living with Temple syndrome need ongoing support for growth, puberty, learning, or weight, but early care can improve day-to-day function and long-term health.
Causes and risk factors
Temple syndrome due to paternal 14q32.2 hypomethylation usually happens because chromosome 14 is switched on in an unusual way before birth. Most cases are not inherited. Risk is mainly genetic, not lifestyle or environmental, though these can affect complications.
Genetic influences
Genetics are central to Temple syndrome due to paternal 14q32.2 hypomethylation, because it results from altered gene control in a specific chromosome 14 region. These changes usually happen sporadically, though testing helps confirm the diagnosis and recurrence risk.
Diagnosis
Doctors usually suspect Temple syndrome from growth, feeding, and puberty patterns, along with clinical features seen on exam. The genetic diagnosis of Temple syndrome is confirmed with methylation testing of chromosome 14q32.2. Sometimes broader genetic tests are also used.
Treatment and drugs
Treatment for Temple syndrome due to paternal 14q32.2 hypomethylation is tailored to each child’s needs. Care often includes feeding support, physical and speech therapy, and school help. Some also need treatment for early puberty, growth, or weight gain.
Symptoms
Children and adults living with Temple syndrome due to paternal 14q32.2 hypomethylation often deal with slow growth, low muscle tone, and changing eating and weight patterns across childhood. The early features of Temple syndrome due to paternal 14q32.2 hypomethylation can include poor feeding, a floppy feel in infancy, and delays in sitting, walking, or speech. Features vary from person to person and can change over time.
Growth may be slower before birth and during childhood, so many people stay shorter than expected for their family. In Temple syndrome, this can mean regular checks of height, weight, and growth over time.
Babies may feel floppy and tire easily during feeds or when held upright. As children grow, lower muscle tone can delay rolling, sitting, walking, and overall stamina.
In infancy, sucking can be weak and feeds may take a long time. Some children then shift from poor early weight gain to later weight gain that rises faster than expected.
Speech, movement, and learning skills can come more slowly, although the range is wide. Some need physical therapy, speech support, or extra help at school, while others have milder challenges.
How people usually first notice Temple syndrome due to paternal 14q32.2 hypomethylation?
How Temple syndrome is first noticed often begins before or soon after birth: many babies are smaller than expected during pregnancy and are born with a low birth weight, and feeding can be difficult in the newborn period. As infancy and early childhood unfold, families and doctors may notice low muscle tone, slow early growth, and later a pattern of short stature, with some children showing early puberty as they get older. The first signs of Temple syndrome can vary, but it is often recognized when a child’s growth and development do not follow the usual pattern and genetic testing is done to look for the cause.
Types of Temple syndrome due to paternal 14q32.2 hypomethylation
No distinct types of Temple syndrome due to paternal 14q32.2 hypomethylation are widely recognized.
Can I slow down the onset of symptoms?
No. For Temple syndrome due to paternal 14q32.2 hypomethylation, the condition begins because of a genetic marking change that is already present before birth, so there is no proven way to delay the start of symptoms with diet, exercise, supplements, or other lifestyle steps. What can help is early supportive care to lessen the impact of some problems over time, such as feeding support, physical and developmental therapy, and close follow-up for growth, early puberty, and weight gain; this may improve daily health, but it does not prevent Temple syndrome or stop symptoms from starting, and early care can still make a real difference.
What genetics can tell you about symptoms
Genetics can give some clues about symptoms in Temple syndrome caused by paternal 14q32.2 hypomethylation, but it usually cannot predict exactly how things will look for any one child. This change affects how a group of genes is switched on and off, and many living with this condition share a pattern of early low muscle tone, feeding or growth concerns in infancy, short stature, early puberty, and later weight gain, although the mix and severity can vary. In general, the genetic finding helps confirm the diagnosis and explain the overall symptom pattern more than it forecasts the exact age symptoms begin or how severe each symptom will be.
Causes and risk factors
Temple syndrome due to paternal 14q32.2 hypomethylation starts with a missing methylation mark, which is a chemical tag, on the father’s copy of a small region on chromosome 14. The genetic cause of Temple syndrome is usually a new change that happens by chance, so it is not usually caused by anything a parent did before or during pregnancy. Rarely, an inherited chromosome change or another imprinting problem can raise the chance of it happening again in a family. There are no proven lifestyle or environmental causes of Temple syndrome itself, but low muscle tone, early puberty, and growth patterns can raise the risk of weight gain and related health problems. Genetic testing can sometimes clarify personal risk for future pregnancies.
What are the most common causes or risk factors?
This form of Temple syndrome is caused by a missing chemical tag on the father’s copy of a small area of chromosome 14, which disrupts how nearby genes are normally controlled. In most families, this happens by chance very early after conception and is not caused by anything the parents did or did not do. Rarely, the chance can be higher if there is another underlying chromosome change or a family problem with these gene-control tags, so genetics testing may help clarify the cause.
Environmental and biological risk factors
Temple syndrome due to paternal 14q32.2 hypomethylation is a rare imprinting disorder that is present from the earliest stages of development. For families wondering about risk factors for Temple syndrome due to paternal 14q32.2 hypomethylation, the main point is that clear environmental triggers have not been proven. In most cases, the change appears to happen as a random biological event very early in development.
This form of Temple syndrome happens when a chemical tag that helps control genes in the 14q32.2 region is missing or reduced on the father's copy. Doctors believe this usually arises by chance around sperm formation, fertilization, or the first cell divisions of the embryo.
The key biological window is the very start of development, before a pregnancy is usually recognized. This helps explain why Temple syndrome due to paternal 14q32.2 hypomethylation is congenital and why a later pregnancy event is often not identified.
No specific maternal illness, infection, medication, or common environmental exposure has been clearly shown to raise the chance of Temple syndrome due to paternal 14q32.2 hypomethylation. At present, there is no well-established preventable outside trigger.
Genetic risk factors
If you are trying to understand the genetic causes of Temple syndrome due to paternal 14q32.2 hypomethylation, the key issue is a missing chemical tag on the father-derived copy of a small region on chromosome 14. That tag helps keep a set of growth-related genes in the right balance. Most cases happen by chance, but a few are linked to tiny inherited changes in the control region that manages this tag. Because of that, family recurrence risk can range from low to higher in selected families.
Missing methylation: The main genetic cause is loss of the normal methylation mark on the father-derived 14q32.2 region. Without this mark, nearby genes that affect growth and development are regulated in the wrong way.
Parent-of-origin: This region is imprinted, which means the maternal and paternal copies are meant to act differently. In Temple syndrome due to paternal 14q32.2 hypomethylation, the paternal copy starts behaving too much like a maternal copy, upsetting that balance.
Chance cases: Most children with this condition have a new, isolated methylation error that happens around conception. That usually means the change was not expected from family history and often carries a low recurrence risk.
Inherited changes: A small deletion or DNA change in the imprinting control region can sometimes cause the paternal methylation mark to be lost. When that kind of change is present, other relatives may also carry it and the family risk can be higher.
Recurrence risk: Recurrence risk depends on the underlying mechanism, so testing may look for both the methylation problem and small changes in the control region. In some cases, genetic testing can give a clearer picture of your personal risk.
Lifestyle risk factors
Temple syndrome due to paternal 14q32.2 hypomethylation is a genetic condition, so lifestyle habits do not cause it. However, how lifestyle affects Temple syndrome can be important for weight gain, muscle strength, bone health, sleep, and day-to-day function. The most helpful approach is to match eating, movement, and routines to the person’s age, growth pattern, and symptoms.
Calorie-dense eating patterns can worsen the tendency toward excess body fat that is often seen in Temple syndrome. Balanced meals with enough protein, fiber, and regular timing may support growth while limiting unnecessary weight gain.
In babies with low muscle tone or early feeding difficulties, overcompensating with high-calorie feeding can later promote rapid catch-up weight gain. Feeding plans guided by swallowing ability, growth, and hunger cues can help avoid both undernutrition and excess fat gain.
Low activity levels can worsen reduced muscle mass, poor endurance, and weight gain in Temple syndrome. Regular age-appropriate movement, strength-building play, and physiotherapy-based exercise may improve mobility, posture, and metabolic health.
Long periods of sitting can add to central weight gain and deconditioning, which are common concerns in Temple syndrome. Breaking up sedentary time with light movement may help preserve fitness and daily function.
Risk prevention
Temple syndrome due to paternal 14q32.2 hypomethylation cannot usually be prevented, because it starts from a change in how a chromosome region is regulated before birth. For many living with Temple syndrome, prevention means lowering the risk of complications and supporting healthy growth, movement, puberty, and day-to-day well-being. Prevention is flexible—it adapts to your life and health background.
Ongoing care with a pediatrician or genetics team can catch issues early, including growth changes, weight gain, and early puberty. This can help prevent small concerns from turning into bigger health problems.
Tracking height, weight, and body composition over time can help guide nutrition and activity plans in Temple syndrome. This may lower the risk of excess weight gain and related problems such as insulin resistance.
Balanced meals, regular meal times, and portion support can be useful because some people with Temple syndrome gain weight easily. A dietitian can help build a plan that supports growth without overfeeding.
Regular movement helps support muscle strength, stamina, bone health, and weight control in Temple syndrome. For many, this can mean simple routines like walking, swimming, or guided play most days of the week.
Can you prevent Temple syndrome due to paternal 14q32.2 hypomethylation?
In most cases, no, this condition cannot be prevented. It usually happens because of a rare change in how certain genes on chromosome 14 are switched on or off before birth, and it is not caused by anything a parent did or did not do. If your family has been affected, meeting with a genetics specialist can help you understand the chance of it happening again and talk through testing options for a future pregnancy, but it cannot guarantee prevention.
Transmission
Temple syndrome due to paternal 14q32.2 hypomethylation is not contagious, so it cannot be passed from one person to another through touch, coughing, sex, food, or everyday contact. For families, the main question is how Temple syndrome due to paternal 14q32.2 hypomethylation is inherited: it happens because a chemical tag that normally helps control gene activity on the father’s copy of chromosome 14 is missing or reduced.
In most cases, this change appears as a new event around conception or very early development rather than being directly passed down through a family. Rarely, an underlying chromosome or imprinting problem in a parent can increase the chance of recurrence, so genetic counseling can help explain the genetic transmission of Temple syndrome due to paternal 14q32.2 hypomethylation for a specific family.
When to test your genes
Testing is most useful when a child has a pattern that fits Temple syndrome, especially poor growth before or after birth, low muscle tone, feeding difficulties, short stature, or unusually early puberty. Early methylation testing of 14q32.2 can confirm the diagnosis and help guide growth, nutrition, puberty, and developmental care.
Diagnosis
Temple syndrome due to paternal 14q32.2 hypomethylation is often suspected when a child has a recognizable pattern of findings, such as low muscle tone in infancy, feeding trouble early on, short height, and weight gain later in childhood. Doctors usually begin with a careful exam and a review of growth, development, and puberty, then confirm the diagnosis of Temple syndrome with specific genetic tests. Getting a diagnosis is often a turning point toward answers and support.
Doctors look for the overall pattern of signs that fit Temple syndrome, rather than relying on one symptom alone. Common clues include low muscle tone, poor feeding in infancy, slower growth, small hands or feet, early puberty, and a tendency to gain excess weight later.
Measurements of height, weight, and head size are compared with growth charts over time. This helps show whether growth is unusually slow in early childhood or whether weight is increasing faster than expected.
The care team asks about motor skills, learning, speech, and day-to-day function. Many living with Temple syndrome have mild developmental or learning differences, and this review helps guide support as well as diagnosis.
Doctors assess whether puberty is starting earlier than expected and may order hormone blood tests if needed. These results can support the genetic diagnosis of Temple syndrome and help plan treatment for growth, weight, and puberty concerns.
How is Temple syndrome due to paternal 14q32.2 hypomethylation diagnosed?
Doctors usually suspect Temple syndrome from a pattern of signs such as slow growth before or after birth, low muscle tone and feeding problems in infancy, shorter height, and puberty starting early, although this can vary from person to person. The diagnosis is usually confirmed with a blood test that checks the chemical tags that help control gene activity in a small part of chromosome 14 called 14q32.2; in this condition, the father’s copy has too little of this marking, which is called hypomethylation. Sometimes doctors also use other genetic tests to make sure a different change in the same area is not causing the symptoms.
Stages of Temple syndrome due to paternal 14q32.2 hypomethylation
Temple syndrome due to paternal 14q32.2 hypomethylation does not have defined progression stages. That is because it is a genetic condition identified by a pattern of features over time, rather than an illness that moves through clear step-by-step phases. Doctors usually start with a conversation about growth, feeding, puberty timing, learning, and family history, along with a physical exam and tracking of height and weight over time. If early symptoms of Temple syndrome are suspected, blood tests and genetic testing can help confirm the diagnosis, and follow-up usually focuses on growth, development, and hormone-related changes as a child gets older.
Outlook and prognosis
The outlook for people with Temple syndrome due to paternal 14q32.2 hypomethylation is generally favorable, especially when growth, nutrition, puberty, and developmental needs are recognized early and managed proactively. Most affected individuals survive into adulthood, and life expectancy is not currently thought to be markedly shortened, although long-term natural history data remain limited because the condition is rare and likely underdiagnosed. Prognosis varies with the severity of early feeding difficulties, short stature, hypotonia, motor and speech delays, learning or behavioral challenges, and the tendency toward early puberty, all of which can affect quality of life if untreated. With multidisciplinary care, many children make developmental progress and can attend school, while endocrine treatment and supportive therapies may improve growth and function. There is no well-established evidence of a high disease-specific mortality rate, and deaths directly attributable to the disorder have not been identified as a typical feature. Ongoing follow-up is important because needs can change over time, particularly around growth, weight management, pubertal development, and psychosocial support.
Long-term effects
Temple syndrome due to paternal 14q32.2 hypomethylation can affect growth, body composition, puberty, and learning from childhood into adult life. Many living with Temple syndrome have a pattern of short stature and a tendency to gain weight more easily over time, even if early feeding was difficult. Long-term effects vary widely, and not everyone has the same mix or severity of features. Understanding the long-term effects of Temple syndrome can help families and clinicians plan for changing needs across life stages.
Many people with Temple syndrome remain shorter than expected as they grow. Some also have smaller hands and feet or a lower muscle mass, which can affect strength and stamina in day-to-day activities.
A common long-term feature is increased body fat, especially around the trunk, with weight gain that may become more noticeable in later childhood or adult life. For many, this can mean clothes fitting differently over time or tiring more easily with physical activity.
Puberty may start earlier than usual, sometimes with a faster shift from childhood into the teen years. This can shorten the time available for growth and may add emotional or social challenges if body changes happen ahead of peers.
In infancy, some children have low muscle tone and feeding difficulties, but these often change with age. Later on, many develop a stronger appetite and easier weight gain, so the long-term picture is often quite different from the early months.
How is it to live with Temple syndrome due to paternal 14q32.2 hypomethylation?
Living with Temple syndrome due to paternal 14q32.2 hypomethylation can look different from one person to the next, but for many it means early challenges with growth, muscle tone, feeding, and later on, learning, behavior, or early puberty, so daily life may involve regular medical visits, therapy, school support, and close attention to nutrition and development. Some people with Temple syndrome are quite independent, while others need more hands-on help with routines, communication, or emotional regulation, and that can shape family schedules, childcare, and school planning in a very real way. For parents, siblings, teachers, and other caregivers, the condition often brings extra coordination and stress, but with the right supports, many families find a rhythm that helps the child or adult living with Temple syndrome take part in home, school, and community life.
Treatment and drugs
Temple syndrome due to paternal 14q32.2 hypomethylation is treated by addressing the specific problems each person has, rather than with one single cure. In infancy and childhood, care may include feeding support, physical and speech therapy, and regular checks of growth, development, and weight, since the early symptoms of Temple syndrome can vary from one child to another. If hormone-related issues are present, such as short stature or puberty starting too early, an endocrinologist may recommend treatment to support growth or delay puberty. Treatment plans often combine several approaches, and many living with Temple syndrome also benefit from nutrition guidance, school supports, and follow-up for learning or behavior needs. Because Temple syndrome can affect people differently, care is usually tailored over time by a team that may include pediatrics, hormone specialists, therapists, and genetics professionals.
Can you cure Temple syndrome due to paternal 14q32.2 hypomethylation?
No, there is not currently a cure for Temple syndrome due to paternal 14q32.2 hypomethylation. Treatment focuses on managing the problems it can cause, such as poor growth, low muscle tone, feeding difficulties, early puberty, and learning or behavior needs, so day-to-day life can be easier and healthier. Regular care from specialists can help adjust support as needs change over time.
Non-drug treatment
Daily care for Temple syndrome due to paternal 14q32.2 hypomethylation often focuses on feeding, movement, growth, learning, and healthy routines. Managing this condition often means starting with therapies and practical supports that help children build strength, eat well, and keep up with day-to-day activities. Because Temple syndrome can look different from one child to another, care is usually tailored over time and may change as early puberty, weight gain, or school challenges become more noticeable.
Babies and young children may need help with latching, sucking, or taking in enough calories, especially if low muscle tone makes feeding tiring. Feeding therapists and dietitians can suggest safer positions, texture changes, and meal plans that support growth without overfeeding.
Physical therapy can help with low muscle tone, delayed walking, poor balance, and reduced stamina. For many children with Temple syndrome, this means practicing strength, posture, and coordination so play, stairs, and getting up from the floor become easier.
Occupational therapy supports everyday skills such as dressing, handwriting, using utensils, and joining in at school or preschool. It can also help with body awareness and fine motor control when small hand movements are hard.
Some children benefit from speech and language therapy for delayed speech, unclear pronunciation, or oral-motor weakness that affects chewing and swallowing. Early support can also help with communication, social interaction, and learning.
Your genes may have an impact on how drugs work for you
For people living with Temple syndrome, treatment is usually aimed at day-to-day concerns such as growth, early puberty, feeding, and weight, and there is no well-established evidence that this condition itself predictably changes how the body responds to the medicines often used for these problems. In other words, the genetic change behind Temple syndrome is important for causing the condition, but it is not currently used in routine care to choose or dose medicines in a special way. Because needs can vary from one person to another, doctors usually adjust treatment based on symptoms, growth, side effects, and regular follow-up rather than on genetic medicine testing.
Pharmacological treatments
There is no single medicine that treats Temple syndrome due to paternal 14q32.2 hypomethylation itself, so drug treatment is usually aimed at the problems it can cause. Many living with this condition need care from a pediatric hormone specialist, because medicines are most often used for early puberty and sometimes for short stature. Not everyone responds to the same medication in the same way. For many families looking into treatment for Temple syndrome due to paternal 14q32.2 hypomethylation, the plan is tailored to age, growth pattern, and symptoms.
Leuprolide, triptorelin, or a histrelin implant may be used if Temple syndrome causes central precocious puberty, meaning puberty starts too early. These medicines lower the brain signals that trigger sex hormones and may help protect adult height.
Somatropin may be considered for some children with short stature or poor growth, especially if they were born small and do not catch up well. It is not a cure for Temple syndrome, but it can support height gain when an endocrinologist feels the benefits outweigh the risks.
If feeding is uncomfortable, doctors may use medicines such as omeprazole or lansoprazole for reflux and polyethylene glycol for constipation. These do not treat the genetic cause, but they can make eating, stooling, and day-to-day comfort easier.
Some older children or adults may develop insulin resistance, type 2 diabetes, or abnormal cholesterol, and standard medicines such as metformin or lipid-lowering drugs may then be prescribed. Alongside drug therapy, regular follow-up, nutrition support, and activity remain important.
Genetic influences
In Temple syndrome due to paternal 14q32.2 hypomethylation, the main genetic issue is a problem with a chemical tag on a small region of chromosome 14, rather than a typical spelling change in a gene. In that region, some genes are meant to be active mainly from the father’s copy, and when that paternal mark is missing or too weak, those genes do not work at the right level. This is an imprinting disorder, meaning the effect depends on which parent the chromosome came from. Most cases happen for the first time in the child and are not passed down in a simple dominant or recessive pattern, although doctors may look for rare chromosome changes that could raise the chance of it happening again in a family. Understanding how Temple syndrome due to paternal 14q32.2 hypomethylation is inherited can help guide testing for the child and, in some families, the parents as well. To put these pieces together, doctors may suggest genetic counseling.
Is Temple syndrome due to paternal 14q32.2 hypomethylation genetic?
Genetics are central to Temple syndrome due to paternal 14q32.2 hypomethylation, because it results from altered gene control in a specific chromosome 14 region. These changes usually happen sporadically, though testing helps confirm the diagnosis and recurrence risk.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct impact on health and simply represent natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with Temple syndrome due to paternal 14q32.2 hypomethylation, treatment is shaped less by one single medicine and more by how growth, feeding, muscle tone, weight, and puberty are affected over time. The underlying genetic change helps confirm the diagnosis and tells doctors to watch closely for common issues such as short stature, early puberty, and a tendency to gain weight easily, which can affect the timing of hormone treatment, nutrition support, and therapies. There is currently no medicine that fixes the methylation change itself, so the best treatment for Temple syndrome due to paternal 14q32.2 hypomethylation is usually personalized, supportive care. Genetics is only one factor, and decisions about growth hormone or medicines used to manage puberty are usually based on age, symptoms, exam findings, and lab results rather than on a Temple syndrome-specific drug test. At this point, there are no well-established pharmacogenetic rules showing that people with Temple syndrome respond to common medicines in a unique way just because of this diagnosis. Still, knowing the genetic cause can help families and clinicians plan follow-up early and choose treatments that fit the problems most likely to appear.
Interactions with other conditions
Many living with Temple syndrome due to paternal 14q32.2 hypomethylation develop health issues that can affect one another over time, especially around growth, puberty, and weight. A common example is Temple syndrome and early puberty: when puberty starts too soon, it can shorten the time available for growth and may worsen short stature if it is not recognized early. Another important aspect is how it may link with other diseases. As children get older, increased body fat can raise the chance of insulin resistance, type 2 diabetes, fatty liver disease, and sleep apnea, so symptoms such as tiredness, snoring, or rapid weight gain should not be brushed off as separate problems. Low muscle tone and feeding difficulties early in life can also make nutrition and physical activity harder to balance later on, which may add to metabolic risk. Because Temple syndrome can overlap with developmental or learning challenges, care often works best when endocrinology, nutrition, and developmental support are coordinated together.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Temple syndrome due to paternal 14q32.2 hypomethylation?
Temple syndrome can look a lot like Prader-Willi syndrome and Silver-Russell syndrome, because all of these can involve poor growth, low muscle tone, feeding problems early in life, and later weight gain or short height. Some children are also first thought to have a simple growth problem, such as low growth hormone, or puberty that starts too early, because those features can stand out more than the full syndrome. Doctors usually tell these apart by looking at the overall pattern of symptoms and, most importantly, with genetic testing.
History
For many living with Temple syndrome due to paternal 14q32.2 hypomethylation, the diagnosis comes only after years of trying to make sense of a pattern that did not seem to fit more familiar conditions. A child may have been smaller than expected before birth, struggled with feeding early on, and later shown a mix of slow growth, early puberty, or learning and behavior differences. This combination was not clearly recognized in older medical writing, partly because the features can overlap with other growth and developmental conditions.
In recent decades, awareness has grown as doctors began grouping these shared features together and comparing them across families and clinics. Temple syndrome was first described in the medical literature in the late 20th century, when specialists reported children with a similar pattern of growth, body composition, and developmental findings. At first, the condition was identified mainly by what doctors could observe over time, not by a lab test, so some children were likely given other diagnoses or no clear diagnosis at all.
As medical science evolved, researchers learned that Temple syndrome is part of a group of conditions linked to changes in how certain genes are regulated rather than changes in the gene code itself. That step mattered because it helped explain why symptoms can vary so much from one person to another, even when the overall pattern is similar. It also improved testing, making it more possible to identify Temple syndrome in children and adults whose early symptoms of Temple syndrome had previously been hard to place.
Today, the history of Temple syndrome reflects a broader shift in medicine: moving from describing outward signs to understanding the underlying biological changes. That has helped doctors recognize the condition earlier, avoid some past confusion with other syndromes, and guide families toward more tailored care. Even so, because Temple syndrome is uncommon and can look different from person to person, diagnosis may still take time.